Hansoh Pharmaceutical Group Company Limited (HKG:3692)

HKG:3692 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	5,555	4,372	3,278	2,584	2,713
Depreciation & Amortization	391.32	401.35	366.38	344.6	278.47
Other Amortization	1.7	-	-	-	-
Loss (Gain) From Sale of Assets	-4.3	-5.72	-2.1	-11.24	-3.94
Asset Writedown & Restructuring Costs	-	31.98	-	-	-
Loss (Gain) From Sale of Investments	16.71	-61.27	-158.22	-67.58	-26.28
Loss (Gain) on Equity Investments	-	-	2.12	13.86	-
Stock-Based Compensation	143.27	137.73	171.37	179.42	65.47
Provision & Write-off of Bad Debts	-0.83	-18.18	22.38	7.15	0.82
Other Operating Activities	-912.65	-1,032	-820.19	-2.96	-22.01
Change in Accounts Receivable	110.08	62.67	341.76	90.45	-549.35
Change in Inventory	20.93	-86.73	-129.54	-40.94	-111.75
Change in Accounts Payable	116.46	54.09	-58.53	-26.03	123.95
Change in Unearned Revenue	1,162	-19.24	13.37	2.9	-173.49
Change in Other Net Operating Assets	137.85	25.38	90.17	-332.15	282.26
Operating Cash Flow	6,738	3,862	3,116	2,741	2,577
Operating Cash Flow Growth	74.46%	23.93%	13.69%	6.37%	7.80%

Investing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-356.43	-221.96	-219.6	-272.82	-460.03
Sale of Property, Plant & Equipment	27.26	23.96	10.96	21.1	54.77
Sale (Purchase) of Intangibles	-133.03	-302.97	-142.93	-19	-15.16
Investment in Securities	-7,902	-1,988	647.54	-5,846	-2,095
Other Investing Activities	1,210	1,097	778	181.17	256.75
Investing Cash Flow	-7,155	-1,392	1,074	-5,935	-2,259

Financing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	500	900	-	-
Long-Term Debt Issued	-	-	-	-	3,877
Total Debt Issued	-	500	900	-	3,877
Short-Term Debt Repaid	-	-500	-900	-	-
Long-Term Debt Repaid	-22.38	-4,204	-18.96	-42.49	-12.29
Total Debt Repaid	-22.38	-4,704	-918.96	-42.49	-12.29
Net Debt Issued (Repaid)	-22.38	-4,204	-18.96	-42.49	3,865
Issuance of Common Stock	3,589	33.19	37.99	13.14	15.11
Repurchase of Common Stock	-	-33.69	-114.87	-76.62	-57.97
Common Dividends Paid	-2,012	-1,858	-652.08	-712.18	-380.87
Other Financing Activities	-	-3.21	-5.77	-	-24.23
Financing Cash Flow	1,554	-6,066	-753.7	-818.14	3,417

Net Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-51.58	-62.43	-122.36	-40.57	-79.29
Net Cash Flow	1,086	-3,658	3,314	-4,053	3,655

Free Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	6,382	3,640	2,897	2,468	2,117
Free Cash Flow Growth	75.31%	25.67%	17.36%	16.60%	119.88%
Free Cash Flow Margin	42.47%	29.69%	28.67%	26.31%	21.31%
Free Cash Flow Per Share	1.07	0.61	0.48	0.42	0.35
Levered Free Cash Flow	5,162	2,401	2,069	1,453	1,256
Unlevered Free Cash Flow	5,163	2,405	2,111	1,489	1,289

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	-	3.21	5.77	-	-
Cash Income Tax Paid	910.59	807.17	589.58	324.03	319.44
Change in Working Capital	1,548	36.16	257.23	-305.78	-428.38

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error